ES
Estrella Immunopharma, Inc.
ESLAW · NASDAQ
$0.06 -4.00% (-$0.00)
1M -10.18%
Market Cap $2.12M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 131.75%
ROA 548.74%
Debt
0 /100
High Current ratio 0.20x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
43 /100
Moderate Profitable years 0
Beta -0.09x
EPS volatility 36.25%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ESLAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheng Liu
Employees
3
Headquarters
EmeryVille
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report